Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the ...

Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that there will be multiple presentations at the American Society of Nephrology (ASN) Kidney Week 2026 ...
DVIDSHub

Opening Plenary Session of the 2017 Global Entrepreneurship Summit

Add the following CSS to the header block of your HTML document. Then add the mark-up below to the body block of the same document. .videoWrapper { position: relative; padding-bottom: 56.25%; ...
UNHCR

ExCom plenary sessions

At its annual session, the Executive Committee (ExCom) reviews the work of the Standing Committee of the preceding year and establishes its programme of work for the next 12 months. It examines ...
Xinhua

Lao leaders hold extraordinary plenary session to discuss key issues

VIENTIANE, Sept. 28 (Xinhua) -- The 12th Central Committee of the Lao People's Revolutionary Party (LPRP) convened an extraordinary plenary session on Monday, chaired by Thongloun Sisoulith, general ...

Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presenta…

Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that there will be multiple ...
MarketScreener

Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ...

BRISBANE - Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, announced that there will be multiple presentations at the American Society of Nephrology (ASN) Kidney Week ...